with Superba™ Krill Oil, to be presented at SupplySide West

Aker BioMarine will share the latest research, including a study benefiting children with an established diagnosis of ADHD

Aker BioMarine announces today that new research, including a clinical study in children with ADHD, will be presented at SupplySide West Friday, October 22 at 10 am. The latest research substantiating Superba™ Krill Oil‘s scientifically proven health benefits, including safety, stability and advanced efficacy as measured by the Omega-3 Index will be presented by Nils Hoem, Ph.D.

“Consumer demand for Krill Oil is gaining momentum due to its unique Omega-3 composition, tolerability and small dose,” said Eric Anderson, Vice President of Sales and Marketing at Aker BioMarine Antarctic US. “Superba™ Krill delivers highly bio-efficient Omega-3 phospholipid EPA & DHA coupled with astaxanthin, a powerful naturally occurring antioxidant, providing real health benefits.”

The presentation will be Friday, October 22nd at 10 AM, Sands Convention Center, Galileo 901.

Additional information will be provided at Aker’s Booth, #24057.


About Superba™ Krill
Superba™ Krill is a pure, natural source of the health-promoting EPA & DHA omega-3 essential fatty acids and the naturally occurring antioxidant astaxanthin. The uniqueness of Superba Krill is that the omega-3 fatty acids are provided in phospholipid form. In vitro, in vivo and human clinical research has demonstrated the safety and efficacy of Superba Krill.

About Aker BioMarine
Aker BioMarine is an integrated biotechnology company dedicated to the sustainable harvesting of krill and development of krill-derived biotech products. The company supplies biomarine ingredients through an optimized value chain from raw materials to customers. Aker BioMarine‘s Superba™ Krill products are provided with 100-percent traceability from the Antarctic sea to the end user. Aker BioMarine is the only krill harvester that has been awarded Marine Stewardship Council (MSC) Certification.

For more information, please contact:
Nils Hoem, Ph.D. Aker BioMarine, +47 24 13 00 00.
Eric Anderson, Aker BioMarine Antarctic US +1 908 858 5068